Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: A meta‐analysis of 75 fMRI studies

HJ Li, XH Hou, HH Liu, CL Yue, Y He… - Human brain …, 2015 - Wiley Online Library
Most of the previous task functional magnetic resonance imaging (fMRI) studies found
abnormalities in distributed brain regions in mild cognitive impairment (MCI) and Alzheimer's …

The effect of combined treatment of psilocybin and eugenol on lipopolysaccharide-induced brain inflammation in mice

T Zanikov, M Gerasymchuk, E Ghasemi Gojani… - Molecules, 2023 - mdpi.com
Inflammation is an organism's biological defense mechanism. Acute and chronic
inflammation of the body triggers the production of pro-and anti-inflammatory pathways that …

Metformin vs sulfonylurea use and risk of dementia in US veterans aged≥ 65 years with diabetes

AR Orkaby, K Cho, J Cormack, DR Gagnon, JA Driver - Neurology, 2017 - AAN Enterprises
Objective: To determine whether metformin is associated with a lower incidence of dementia
than sulfonylureas. Methods: This was a retrospective cohort study of US veterans≥ 65 …

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession

D Liu, M Pitta, H Jiang, JH Lee, G Zhang, X Chen… - Neurobiology of …, 2013 - Elsevier
Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline
and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in …

Successful brain aging: plasticity, environmental enrichment, and lifestyle

F Mora - Dialogues in clinical neuroscience, 2013 - Taylor & Francis
Aging is a physiological process that can develop without the appearance of concurrent
diseases. However, very frequently, older people suffer from memory loss and an …

[HTML][HTML] Implantable biosensors and their contribution to the future of precision medicine

M Gray, J Meehan, C Ward, SP Langdon… - The Veterinary …, 2018 - Elsevier
Precision medicine can be defined as the prevention, investigation and treatment of
diseases taking individual variability into account. There are multiple ways in which the field …

Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease

Z Yao, W Yang, Z Gao, P Jia - Neuroscience letters, 2017 - Elsevier
Amyloid-β (Aβ) oligomers have been accepted as major neurotoxic agents in the therapy of
Alzheimer's disease (AD). It has been shown that the activity of nicotinamide adenine …

Luteolin protects against high fat diet-induced cognitive deficits in obesity mice

Y Liu, X Fu, N Lan, S Li, J Zhang, S Wang, C Li… - Behavioural brain …, 2014 - Elsevier
The epidemic and experimental studies have confirmed that the obesity can lead to
neuroinflammation, neurodegenerative diseases and adversely affect cognition. Despite the …

[HTML][HTML] SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases

H Meng, WY Yan, YH Lei, Z Wan, YY Hou… - Frontiers in aging …, 2019 - frontiersin.org
Neurodegenerative diseases are disorders that are characterized by a progressive decline
of motor and/or cognitive functions caused by the selective degeneration and loss of …

Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation

D Obregon, H Hou, J Deng, B Giunta, J Tian… - Nature …, 2012 - nature.com
In sporadic age-related forms of Alzheimer's disease (AD), it is unclear why amyloid-β (Aβ)
peptides accumulate. Here we show that soluble amyloid precursor protein-α (sAPP-α) …